MARÍA ISABEL CEBEIRA MATEOS-rekin lankidetzan egindako argitalpenak (10)

2002

  1. Exposure to cannabinoids in the development of endogenous cannabinoid system

    Neurotoxicity Research, Vol. 4, Núm. 4, pp. 363-372

2000

  1. Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme

    Brain Research, Vol. 857, Núm. 1-2, pp. 56-65

1998

  1. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development

    Development, Vol. 125, Núm. 16, pp. 3179-3188

1994

  1. Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin

    Journal of Neural Transmission, Vol. 96, Núm. 1, pp. 63-79

1993

  1. An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity

    Behavioural Brain Research, Vol. 57, Núm. 1, pp. 37-46

  2. Motor disturbances induced by an acute dose of Δ9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations

    Pharmacology, Biochemistry and Behavior, Vol. 45, Núm. 2, pp. 291-298

1992

  1. Comparisons between brain dopaminergic neurons of juvenile and aged rats: Sex-related differences

    Mechanisms of Ageing and Development, Vol. 63, Núm. 1, pp. 45-55

  2. Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice

    Pharmacology, Biochemistry and Behavior, Vol. 43, Núm. 2, pp. 603-608

1991

  1. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels

    Life Sciences, Vol. 48, Núm. 6, pp. 531-541

1990

  1. Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats

    Developmental Brain Research, Vol. 51, Núm. 2, pp. 237-240